... F-florbetaben positron emission tomography imaging. Results: Automated region-of-interest analysis showed significant increases in 18 F-florbetaben uptake in several brain regions in INPH patients compared to control subjects, with especially remarkable increases in the frontal (bilateral), parietal...

... with Lewy bodies (DLB) show Alzheimer's disease pathology-like senile plaques and neurofibrillary tangles. Several studies have also revealed a high prevalence of positive amyloid imaging with positron emission tomography (PET) in DLB and moderate prevalence in Parkinson's disease (PD) with dementia...

... impairment in Parkinson’s disease with dementia (PDD), the responsiveness of patients to donepezil therapy varies. [5- 11 C-methoxy]donepezil, the radiolabeled form of donepezil, is a ligand for positron emission tomography (PET), which can be exploited for the quantitative analysis of donepezil binding...

... metabolism patterns by positron emission tomography (PET) and the changes following donepezil treatment. 13 DLB patients with VHs were enrolled in the study. After the first FDG-PET study, 5 mg/day donepezil was administered orally, and a second PET study was performed 3 months later. After donepezil...

.... Parkinson’s disease Mild cognitive impairment Positron emission tomography About a third of Parkinson’s disease (PD) patients are demented at a given time [ 1,2,3 ]. In addition to levodopa-resistant motor symptoms, dementia is another major cause leading to nursing home placement, disability...

...H.G. Wieser Positron emission tomography (PET) measures regional cerebral metabolism and blood flow. PET imaging has been quite successful in identifying focal epileptogenesis as an area of hypometabolism between attacks. PET has proven to be an important diagnostic tool in selecting patients...

... and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Positron emission tomography Fluorodeoxyglucose Stroke Diaschisis ...

... and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Progressive supranuclear palsy Positron emission tomography Frontal hypometabolism Alzheimer’s disease 9 10...

... rates mainly in the white matter indicated the occurrence of delayed ischemic changes. The positron emission tomography and CT findings correlated well with the degree of posthypoxic-ischemic damage and the clinical status of the studied subjects. 24 01 1992 16 06 1992 12 2 2008 ©...

... brovincamine administration. It was concluded that brovincamine might be useful for increasing the hemodynamic reserve, but did not affect the metabolic state immediately after its administration. Cerebral blood flow Cerebral metabolic rate of oxygen Positron emission tomography Brovincamine Internal...

... in patients with, at that time, no obvious mental deterioration are premonitory signs of an encephalopathy of unknown origin, possibly leading to cognitive decline. 2 11 1994 10 04 1995 12 2 2008 Late-onset epilepsy Leukoaraiosis Mental deterioration Positron emission tomography...

... blood flow, oxygen extraction rate and oxygen consumption, determined by the [ 15 O] steady-state technique with positron emission tomography. Thirty patients, classified according to the presence or absence of leukoaraiosis and their mental status, are examined. The occurrence and severity of dementia...

...J. De Reuck; J. Van Aken; W. Van Landegem; F. Colardyn Three patients with neuroleptic malignant syndrome were studied by positron emission tomography (PET), using the steady-state technique with C 15 O 2 and 15 O 2 . In 2 patients the PET examination was repeated after resolution of the syndrome...

..., instructions or products referred to in the content or advertisements. Positron emission tomography Magnetic resonance imaging Alzheimer’s disease Multi-infarct dementia ...

...G.L. Lenzi; R.S.J. Frackowiak; T. Jones; J.D. Heather; A.A. Lammertsma; C.G. Rhodes; C. Pozzilli The oxygen-15 inhalation technique has been applied to the quantitation of regional CBF, CMRO 2 and OER with positron emission tomography. The introduction of corrections for gamma-ray attenuation...

...J.C. Baron; M.G. Bousser; D. Comar; F. Soussaline; P. Castaigne The non-invasive continuous inhalation technique of C 15 O 2 and 15 O 2 coupled with positron emission tomography (PET) provides brain images that are thought to represent local cerebral blood flow (CBF) and oxygen extraction fraction...

...David J. Brooks 18 F-Dopa positron emission tomography (PET) provides a sensitive means of quantitating the loss of nigrostriatal dopaminergic fibres in Parkinson''s disease and so can be used to diagnose its presence and to objectively follow the rate of disease progression. It can also be used...

...Aaron M. McMurtray; Eliot Licht; Tuty Yeo; Erica Krisztal; Ronald E. Saul; Mario F. Mendez Background: Clinical positron emission tomography (PET) may help in the evaluation of presenile patients with memory complaints for the presence of Alzheimer’s disease (AD). Methods: Clinical PET scans from...

...(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Post-ischaemic-hypoxic amnesia Positron emission tomography Acetazolamide vasoreactivity Frontal lobe dysfunction...

...Seung Bong Hong; Hyun Jeong Han; Suk-Young Roh; Dae Won Seo; Sang Eun Kim; Myoung-Hee Kim To study the influence of interictal spikes on 18 F-fluorodeoxyglucose positron emission tomography (FDG-PET), EEG monitoring was performed during PET scanning in 21 patients with temporal lobe epilepsy...